Morning Market Movers
April 04, 2013 at 10:17 AM EDT
CollabRx (NASDAQ: CLRX ) shares advanced 40.59% to $4.48 after the company and OncoDNA announced a multi-year agreement to purchase CollabRx SaaS-based technology and content resources to be used in conjunction with OncoDNA's cancer mutation panels. CombiMatrix (NASDAQ: CBMX ) climbed 26.30% to $4.37 after the company reported that
